在糖尿病患者的总死亡率中80%系由主要的心血管事件引起。
Major cardiovascular events cause about 80% of the total mortality in diabetic patients.
该试验的主要结果，如先前报告显示：在阿托伐他汀治疗组，患者中风和主要心血管事件发生率均显著降低。
The trial's main results, previously reported, showed that patients in the atorvastatin group were significantly less likely to experience both stroke and major cardiovascular events.
与心血管事件相关的主要并发症仍是卒中。
The main complication associated with cardiovascular events is still stroke.
两组的30天主要不良心血管事件差异无统计学意义（P>0.05）。
There were no significant differences for major cardiovascular events in 30 days between two groups, P>0.05.
药物治疗是减少冠心病介入术后支架内再狭窄、降低远期主要心血管事件的主要手段。
Medicine treatment plays key role in reducing the rate of restenosis and major adverse cardiac events.
结论吸烟和糖尿病是原发性高血压患者发生新发心血管事件的主要可干预危险因素。
Conclusion Smoking and diabetes are the major risk factors of new onset CVD event in hypertensive patients.
结论吸烟和糖尿病是原发性高血压患者发生新发心血管事件的主要可干预危险因素。
Conclusion Smoking and diabetes are the major risk factors of new onset CVD event in hypertensive patients.
应用推荐